20 |
Klinisk Biokemi i Norden · 2 2017
sured by a direct homogeneous assay and by
the Friedewald formula in a large community
population. Clin Chim Acta 2010;411:1774-80.
20. Mora S, Rifai N, Buring JE, Ridker PM. Com-
parison of LDL cholesterol concentrations by
Friedewald calculation and direct measurement
in relation to cardiovascular events in 27,331
women. Clin Chem 2009;55:888-94.
21. Varbo A, Benn M, Tybjaerg-Hansen A, Jor-
gensen AB, Frikke-Schmidt R, Nordestgaard
BG. Remnant cholesterol as a causal risk factor
for ischemic heart disease. J Am Coll Cardiol
2013;61:427-36.
22. Varbo A, Benn M, Tybjaerg-Hansen A, Nord-
estgaard BG. Elevated remnant cholesterol cau-
ses both low-grade inflammation and ischemic
heart disease, whereas elevated low-density
lipoprotein cholesterol causes ischemic heart
disease without inflammation. Circulation
2013;128:1298-309.
23. Nordestgaard BG, Varbo A. Triglycerides and
cardiovascular disease. Lancet 2014;384:626-35.
24. Kamstrup PR, Tybjaerg-Hansen A, Steffen-
sen R, Nordestgaard BG. Genetically elevated
lipoprotein(a) and increased risk of myocardial
infarction. JAMA 2009;301:2331-9.
25. Kinpara K, Okada H, Yoneyama A, Okubo M,
Murase T. Lipoprotein(a)-cholesterol: a signi-
ficant component of serum cholesterol. Clin
Chim Acta 2011;412:1783-7.
26. Hegele RA, Ginsberg HN, ChapmanMJ, Nord-
estgaard BG, Kuivenhoven JA, Averna M. et.
al. The polygenic nature of hypertriglyceri-
daemia: implications for definition, diagnosis,
and management. Lancet Diabetes Endocrinol
2014;2:655-66.
27. Cohn JS, McNamara JR, Schaefer EJ. Lipopro-
tein cholesterol concentrations in the plasma
of human subjects as measured in the fed and
fasted states. Clin Chem 1988;34:2456-9.
28. Mihas C, Kolovou GD, Mikhailidis DP, Kovar
J, Lairon D, Nordestgaard BG. et. al. Diagnostic
value of postprandial triglyceride testing in
healthy subjects: a meta-analysis. Curr Vasc
Pharmacol 2011;9:271-80.
29. Klop B, Cohn JS, van Oostrom AJ, van Wijk
JP, Birnie E, Castro CM. Daytime triglyceride
variability in men and women with diffe-
rent levels of triglyceridemia. Clin Chim Acta
2011;412:2183-9.
30. Sidhu D, Naugler C. Fasting time and lipid levels
in a community-based population: a cross-sec-
tional study. Arch Intern Med 2012;172:1707-10.
31. Steiner MJ, Skinner AC, Perrin EM. Fasting
might not be necessary before lipid screening: a
nationally representative cross-sectional study.
Pediatrics 2011;128:463-70.
32. Nordestgaard BG, Benn M, Schnohr P, Tyb-
jaerg- Hansen A. Nonfasting triglycerides and
risk of myocardial infarction, ischemic heart
disease, and death in men and women. JAMA
2007;298:299-308.
33. Martin SS, Blaha MJ, Elshazly MB, Toth PP,
Kwiterovich PO, Blumenthal RS, Jones SR.
Comparison of a novel method vs the Friedewald
equation for estimating low-density lipoprotein
cholesterol levels from the standard lipid profile.
JAMA 2013;310:2061-8.
34. Lund SS, Jensen T. Using nonfasting lipids-
-hemodilution or convenience? Clin Chem
2011;57:1336-8.
35. Langsted A, Kamstrup PR, Nordestgaard BG.
Lipoprotein(a): fasting and nonfasting levels,
inflammation, and cardiovascular risk. Athe-
rosclerosis 2014;234:95-101.
36. White KT, Moorthy MV, Akinkuolie AO, Dem-
ler O, Ridker PM, Cook NR, Mora S. Identify-
ing an Optimal Cutpoint for the Diagnosis of
Hypertriglyceridemia in the Nonfasting State.
Clin Chem 2015;61:1156-63.
37. Langsted A, Nordestgaard BG. Nonfasting Lipid
Profiles: The Way of the Future. Clin Chem
2015;61:1123-5.
38. Stone NJ, Robinson JG, Lichtenstein AH, Bairey
Merz CN, Blum CB. 2013 ACC/AHA guideline
on the treatment of blood cholesterol to reduce
atherosclerotic cardiovascular risk in adults: a
report of the American College of Cardiology/
American Heart Association Task Force on Prac-
tice Guidelines. J AmColl Cardiol 2014;63:2889-
934.
39. Jessen RH, Dass CJ, Eckfeldt JH. Do enzymatic
analyses of serum triglycerides really need blan-
king for free glycerol? Clin Chem1990;36:1372-5.
